Home/Perimeter Systems, Inc./Dr. Michael Chen
DM

Dr. Michael Chen

CEO

Perimeter Systems, Inc.

Therapeutic Areas

Perimeter Systems, Inc. Pipeline

DrugIndicationPhase
PS-101Solid TumorsPreclinical
PS-102Hematological MalignanciesPreclinical